ucsf logobch logo

Jason H. Pomerantz, MD

Plastic Surgery • Reconstructive Plastic SurgerySurgical Director, Craniofacial Center
Portrait of Jason H. Pomerantz
Portrait of Jason H. Pomerantz
ucsf logobch logo

Jason H. Pomerantz, MD

Plastic Surgery • Reconstructive Plastic SurgerySurgical Director, Craniofacial Center

On this page

About me

Dr. Jason H. Pomerantz is a plastic surgeon who specializes in pediatric plastic and reconstructive surgery, including the treatment of craniofacial anomalies (abnormalities of the head and face). He cares for adults as well as children with congenital or acquired deformities, such as cleft lip and palate, craniosynostosis (a birth defect involving skull bones) and facial injuries.

In his research, Pomerantz focuses on tissue regeneration and maintenance by stem cells, with the goal of optimizing tissue repair and correcting deformities associated with development, injury or disease.

Pomerantz earned his medical degree at the Albert Einstein College of Medicine. He completed a residency in plastic surgery at UCSF, a postdoctoral research fellowship in regeneration biology at Stanford University and a fellowship in craniofacial surgery at the University of Washington.

Education & training

Board certification

  • Plastic Surgery, American Board of Plastic Surgery

Fellowship

  • Cleft & Craniofacial Surgery, Stanford University Medical Center-GME

Residency

  • Plastic Surgery, UCSF Graduate Medical Education

Internship

  • Plastic Surgery, UCSF Graduate Medical Education

Degree

  • MD, Yeshiva University Albert Einstein College of Medicine

My expertise

Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.